Product Description
| Brand |
Snibe |
| Sample Type |
Serum |
| Pack Size |
100T |
| CAT No. |
130255005M |
| Application |
Gastro-Intestinal |
The kit has been designed for the quantitative determination of glutamic acid decarboxylase antibody (GAD65) in human serum. The method can be used for samples over the range of 1.0-280.0 IU/ml. The test has to be performed on the Fully-auto chemiluminescence immunoassay (CLIA) analyzer MAGLUMI (Including Maglumi 600,Maglumi 1000,Maglumi 1000 Plus, Maglumi 2000,Maglumi 2000 Plus,Maglumi 3000 and Maglumi 4000).
Advanced Detection for Diabetes DiagnosisThe MAGLUMI GAD65 (CLIA) reagent kit targets the accurate and sensitive quantification of GAD65 autoantibodies, helping to differentiate and diagnose Type 1 Diabetes Mellitus effectively. Its high specificity ensures reliable results essential for clinical decision-making in laboratories.
Streamlined Automated WorkflowBy being fully compatible with MAGLUMI Series Immunoassay Analyzers, this kit supports real-time, fully automated operation. Lab technicians benefit from reduced hands-on time, consistent reagent quality, and improved throughput, making large-scale diagnoses more efficient.
User-Friendly and Reliable OperationDelivered in a ready-to-use format, the reagent kit simplifies laboratory processes. Integrated quality controls and comprehensive lot traceability enhance reliability, while an extended shelf life and straightforward storage requirements add further convenience.
FAQ's of Snibe MAGLUMI GAD65 (CLIA):
Q: How does the Snibe MAGLUMI GAD65 (CLIA) kit detect GAD65 autoantibodies?
A: The Snibe MAGLUMI GAD65 utilizes a sandwich chemiluminescence immunoassay technique, allowing for quantitative detection of GAD65 autoantibodies in human serum or plasma with high specificity and sensitivity.
Q: What sample types are suitable for this test and where should it be performed?
A: This kit is intended for use with human serum or plasma and should be operated in a clinical laboratory setting using MAGLUMI Series Immunoassay Analyzers.
Q: When should the Snibe MAGLUMI GAD65 (CLIA) be used in clinical practice?
A: It should be employed when Type 1 Diabetes Mellitus is suspected and there is a need to measure GAD65 autoantibodies as part of the diagnostic process.
Q: What is the typical process for running a test with this kit?
A: Simply load the ready-to-use reagents and patient samples onto the compatible MAGLUMI analyzer. The analyzer automates the assay, and quantitative results are generated in about 40 minutes per sample.
Q: What are the main benefits of using this reagent kit?
A: Users benefit from quick, accurate diagnoses with high throughput, minimal hands-on operation, built-in quality control, and the assurance of lot traceability for robust, reproducible testing.
Q: How should the reagent kit be stored and what is its shelf life?
A: The kit should be stored at 2-8C and offers a shelf life of 12 months, making it suitable for regular clinical laboratory workflows.